2026 NPPES data Nuclear Medicine Physician NPI 1790791887 MD
Verify on CMS →

JAGDISH MISHRA, MD

Nuclear Medicine Physician in BATAVIA, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 938 beneficiaries · Nuclear Medicine Physician avg: 881
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
50.7886/100
▼ 32 pts below national avg 83.1 · [object Object]
Industry payments
$1.6K
56 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JAGDISH MISHRA, MD reported a CMS MIPS final score of 50.7886/100 — below the 83.1 national average — and filed 6,969 Medicare Part D claims in 2023.

50.7886/100
MIPS score · -32 vs avg
7K
Part D claims, 2023
76%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JAGDISH MISHRA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

51 4th percentile higher than 4% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). This entry sits in this band. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JAGDISH MISHRA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JAGDISH MISHRA, MD?

Below national average

NPI registry status

Active

Issued 07/31/2006

NPI 1790791887

Primary specialty

Nuclear Medicine Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

6,969 691% vs specialty avg

2023 prescription claims

Specialty avg: 881

MIPS final score

50.7886/100 32.31139999999999% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in New York

How Nuclear Medicine Physician compares to other specialties among New York providers

New York providers

Nuclear Medicine Physician share within New York

1. Nuclear Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nuclear Medicine Physician share within New York

Medicare quality performance — MIPS

JAGDISH MISHRA, MD's 2023 MIPS final score plotted against the Nuclear Medicine Physician national average

Below national average
MIPS Final Score
50.7886/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Nuclear Medicine Physician) — 50.7886/100 vs national avg 83.1

0%100%National avg83%50.8%
MIPS final score (Nuclear Medicine Physician) — 50.7886/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JAGDISH MISHRA, MD appears in the CMS NPPES registry as a Nuclear Medicine Physician provider holding MD credentials at 229 SUMMIT ST STE 9, BATAVIA, NY, 14020, with a listed phone of (585) 343-3205. NPI 1790791887 was issued on 07/31/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MISHRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 6,969 prescription claims written by this provider, covering 938 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 24% brand-name and 76% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 50.7886/100 for the 2023 performance year (Quality 42.4897, Cost 94.1386), compared with the national average of 83.1.

Nuclear Medicine Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 881 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

229 SUMMIT ST STE 9
BATAVIA, NY 14020

Provider Details

NPI 1790791887
Specialty Nuclear Medicine Physician
Credentials MD
Gender Male
NPI Issued 07/31/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

50.7886
Final Score
Avg: 83.1
42.4897
Quality
94.1386
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JAGDISH MISHRA, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.6K

Largest payer

BIOTRONIK INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to JAGDISH MISHRA, MD. To verify JAGDISH MISHRA, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JAGDISH MISHRA, MD — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 6,969 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

6,969
Total Claims
$1.4M
Total Drug Cost
938
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
14,197
Total Day Supply
423,511
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$128K

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
1.48
Gender Split
52% female / 48% male
Age Distribution
<65: 101, 65-74: 366, 75-84: 329, 85+: 142

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JAGDISH MISHRA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Metoprolol Succinate
863
Furosemide
650
Eliquis
Apixaban
564
Metoprolol Tartrate
559
Entresto
Sacubitril/Valsartan
375
Amlodipine Besylate
335
Torsemide
305
Xarelto
Rivaroxaban
286
Irbesartan-Hydrochlorothiazide
Irbesartan/Hydrochlorothiazide
217
Clopidogrel
Clopidogrel Bisulfate
164

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nuclear Medicine Physician Overview

How JAGDISH MISHRA, MD fits within the Nuclear Medicine Physician landscape nationally.

913
Nuclear Medicine Physician Providers in US
48
States with Nuclear Medicine Physician
881
Avg Claims per Provider

JAGDISH MISHRA, MD's 6,969 claims are above the specialty average of 881.

Nearby Nuclear Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MISHRA.

Compare Nuclear Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JAGDISH MISHRA, MD's specialty?
JAGDISH MISHRA, MD specializes in Nuclear Medicine Physician and practices in BATAVIA, New York. Credentials: MD.
How much does JAGDISH MISHRA, MD prescribe under Medicare Part D?
In 2023, JAGDISH MISHRA, MD wrote 6,969 Medicare Part D claims totaling $1.4M in drug costs for 938 beneficiaries.
What is JAGDISH MISHRA, MD's Medicare quality score?
JAGDISH MISHRA, MD has a CMS MIPS Final Score of 50.7886/100 (Quality: 42.4897, Cost: 94.1386). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JAGDISH MISHRA, MD located?
JAGDISH MISHRA, MD is located at 229 SUMMIT ST STE 9, BATAVIA, NY, 14020. Phone: (585) 343-3205.
What is JAGDISH MISHRA, MD's NPI number?
JAGDISH MISHRA, MD's National Provider Identifier (NPI) is 1790791887, issued on 07/31/2006.
Does JAGDISH MISHRA, MD prescribe more brand-name or generic drugs?
JAGDISH MISHRA, MD's prescribing is 24% brand-name and 76% generic drugs by claim count, with $1.2M in brand drug costs.
How many Nuclear Medicine Physician providers are there in the US?
There are 913 Nuclear Medicine Physician providers across 48 states in the US. The average Nuclear Medicine Physician provider writes 881 Medicare Part D claims per year.
What drugs does JAGDISH MISHRA, MD prescribe most often?
Based on 2023 Medicare Part D data, JAGDISH MISHRA, MD's most frequently prescribed drugs include Metoprolol Succinate, Furosemide, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JAGDISH MISHRA, MD accept Medicare?
JAGDISH MISHRA, MD appears in CMS Medicare data with 6,969 Part D claims and 938 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JAGDISH MISHRA, MD's credentials?
JAGDISH MISHRA, MD's NPI is 1790791887 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology